# Promethazine vs. Lorazepam for Treatment of Vertigo

> **NCT01827293** · PHASE3 · COMPLETED · sponsor: **Shahid Beheshti University of Medical Sciences** · enrollment: 210 (actual)

## Conditions studied

- Peripheral Vertigo.

## Interventions

- **DRUG:** Promethazine
- **DRUG:** Lorazepam

## Key facts

- **NCT ID:** NCT01827293
- **Lead sponsor:** Shahid Beheshti University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2013-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01827293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01827293, "Promethazine vs. Lorazepam for Treatment of Vertigo". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01827293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*